PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation.

The genetic aberrations that drive mixed phenotype acute leukemia (MPAL) remain largely unknown, with the exception of a small subset of MPALs harboring BCR -ABL1 and MLL translocations. We performed clinicopathologic and genetic evaluation of 52 presumptive MPAL cases at Memorial Sloan Kettering Cancer Center. Only 29 out of 52 (56%) cases were confirmed to be bona fide MPAL according to the 2016 World Heath Organization classification. We identified PHF6 and DNMT3A mutations as the most common recurrent mutations in MPAL, each occurring in 6 out of 26 (23%) cases. These mutations are mutually exclusive of each other and BCR-ABL1/MLL translocations. PHF6- and DNMT3A-mutated MPAL showed marked predilection for T-lineage differentiation (5/6 PHF6 mutated, 6/6 DNMT3A mutated). PHF6-mutated MPAL occurred in a younger patient cohort compared with DNMT3A-mutated cases (median age, 27 years vs 61 years, P < .01). All 3 MPAL cases with both T- and B-lineage differentiation harbored PHF6 mutations. MPAL with T-lineage differentiation was associated with nodal or extramedullary involvement (9/15 [60%] vs 0, P = .001) and a higher relapse incidence (78% vs 22%, P = .017) compared with those without T-lineage differentiation. Sequencing studies on flow-cytometry-sorted populations demonstrated that PHF6 mutations are present in all blast compartments regardless of lineage differentiation with high variant allele frequency, implicating PHF6 as an early mutation in MPAL pathogenesis. In conclusion, PHF6 and DNMT3A mutations are the most common somatic alterations identified in MPAL and appear to define 2 distinct subgroups of MPAL with T-lineage differentiation with inferior outcomes.

[1]  K. Manola.  Cytogenetic abnormalities in acute leukaemia of ambiguous lineage: an overview , 2013, British journal of haematology.

[2]  S. Bohlander,et al.  Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations. , 2013, Blood.

[3]  T. Druley,et al.  Dnmt3a Regulates T-cell Development and Suppresses T-ALL Transformation , 2017, Leukemia.

[4]  Jason D. Buenrostro,et al.  PHF6 regulates phenotypic plasticity through chromatin organization within lineage-specific genes , 2017, Genes & development.

[5]  T. Kalina,et al.  Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria , 2010, Haematologica.

[6]  A. Børresen-Dale,et al.  The Life History of 21 Breast Cancers , 2012, Cell.

[7]  J. Cen,et al.  TAF15-ZNF384 fusion gene in childhood mixed phenotype acute leukemia. , 2017, Cancer genetics.

[8]  H. Matsuoka,et al.  Mixed Phenotype Acute Leukemia with t(12;17)(p13;q21)/TAF15-ZNF384 and Other Chromosome Abnormalities , 2016, Cytogenetic and Genome Research.

[9]  Keiran M Raine,et al.  cgpPindel: Identifying Somatically Acquired Insertion and Deletion Events from Paired End Sequencing , 2015, Current protocols in bioinformatics.

[10]  Jihui Wu,et al.  Structural Basis of Plant Homeodomain Finger 6 (PHF6) Recognition by the Retinoblastoma Binding Protein 4 (RBBP4) Component of the Nucleosome Remodeling and Deacetylase (NuRD) Complex* , 2015, The Journal of Biological Chemistry.

[11]  D. Gerhard,et al.  Genomic Landscape of Pediatric Mixed Phenotype Acute Leukemia , 2016 .

[12]  J. Choi,et al.  Molecular characterization of alternative SET-NUP214 fusion transcripts in a case of acute undifferentiated leukemia. , 2010, Cancer genetics and cytogenetics.

[13]  Vahid Asnafi,et al.  The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest , 2013, Haematologica.

[14]  W. Hiddemann,et al.  MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis. , 1998, Blood.

[15]  G. Wertheim,et al.  Mixed Phenotype Acute Leukemia with Low Hypodiploidy in a Pediatric Patient , 2015, Journal of pediatric oncology.

[16]  H. Drexler,et al.  SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines , 2009, Journal of hematology & oncology.

[17]  M. Dubé,et al.  DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions. , 2017, Blood.

[18]  Mario Cazzola,et al.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.

[19]  Alex M. Fichtenholtz,et al.  Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting. , 2016, Blood.

[20]  Junjie Chen,et al.  PHF6 regulates cell cycle progression by suppressing ribosomal RNA synthesis , 2012, Epigenetics & Chromatin.

[21]  Donavan T. Cheng,et al.  Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. , 2015, The Journal of molecular diagnostics : JMD.

[22]  Jianmin Yang,et al.  Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that of acute myeloid leukemia and acute lymphoblastic leukemia: a case series of a Chinese population , 2009, Haematologica.

[23]  G. Ossenkoppele,et al.  Acute leukemias of ambiguous lineage: diagnostic consequences of the WHO2008 classification , 2010, Leukemia.

[24]  D. Picketts,et al.  PHF6 interacts with the nucleosome remodeling and deacetylation (NuRD) complex. , 2012, Journal of proteome research.

[25]  M. Fornerod,et al.  PHF6 mutations in paediatric acute myeloid leukaemia , 2016, British journal of haematology.

[26]  J. Downing,et al.  Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital. , 2009, Blood.

[27]  D. Wheeler,et al.  Mixed-phenotype acute leukemia (MPAL) exhibits frequent mutations in DNMT3A and activated signaling genes. , 2016, Experimental hematology.

[28]  A. Porwit,et al.  Acute leukemias of ambiguous origin. , 2015, American journal of clinical pathology.

[29]  D. Zheng,et al.  Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development. , 2016, Cancer cell.

[30]  P. A. Futreal,et al.  Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes , 2018, Nature Communications.

[31]  E. Wolf,et al.  The target cell of transformation is distinct from the leukemia stem cell in murine CALM/AF10 leukemia models , 2016, Leukemia.

[32]  S. Jang,et al.  Stem cell transplant in the treatment of childhood biphenotypic acute leukemia , 2009, Pediatric blood & cancer.

[33]  R. Levine,et al.  Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[34]  Lincoln D. Stein,et al.  Identification of pre-leukemic hematopoietic stem cells in acute leukemia , 2014, Nature.

[35]  A. Kentsis,et al.  Acute myeloid/T‐lymphoblastic leukaemia (AMTL): a distinct category of acute leukaemias with common pathogenesis in need of improved therapy , 2018, British journal of haematology.

[36]  Richard A. Moore,et al.  The genetic basis and cell of origin of mixed phenotype acute leukaemia , 2018, Nature.

[37]  R. Wilson,et al.  CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression , 2017, Cell.

[38]  S. Miyano,et al.  Somatic PHF6 mutations in 1760 cases with various myeloid neoplasms , 2016, Leukemia.

[39]  T. Owaidah,et al.  Cytogenetics, molecular and ultrastructural characteristics of biphenotypic acute leukemia identified by the EGIL scoring system , 2006, Leukemia.

[40]  A. Alizadeh,et al.  Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria. , 2014, American journal of clinical pathology.

[41]  A. Órfão,et al.  Mixed phenotype acute leukemia (MPAL): clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification Authors: , 2011 .

[42]  M. Rudnicki,et al.  The X-Linked Intellectual Disability Protein PHF6 Associates with the PAF1 Complex and Regulates Neuronal Migration in the Mammalian Brain , 2013, Neuron.

[43]  F. Locatelli,et al.  Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia , 2013, Leukemia.

[44]  J. H. Lee,et al.  Prognostic implications of the immunophenotype in biphenotypic acute leukemia , 2006, Leukemia & lymphoma.

[45]  J. Aster,et al.  Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T‐ALL like mutations , 2018, American journal of hematology.

[46]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[47]  M. Dubé,et al.  Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A. , 2018, Blood.

[48]  J. Aster,et al.  Novel SSBP2‐JAK2 fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre‐B acute lymphocytic leukemia , 2008, Genes, chromosomes & cancer.

[49]  D. Arber,et al.  Mixed-phenotype acute leukemia: historical overview and a new definition , 2010, Leukemia.

[50]  Jie Jin,et al.  Mixed T/myeloid phenotype acute leukemia with rare variants of IDH1 and CEBPA , 2013, Leukemia & lymphoma.

[51]  S. Salzberg,et al.  Genomic characterization of chromosome translocations in patients with T/myeloid mixed-phenotype acute leukemia , 2018, Leukemia & lymphoma.

[52]  Lincoln D. Stein,et al.  DNMT3a Mutations Define a Pre-Leukemic Stem Cell Reservoir In Human Acute Myeloid Leukemia , 2013 .

[53]  M. Ayas,et al.  Clinical characteristics and outcome of children with biphenotypic acute leukemia , 2009, Haematologica.

[54]  A. Ferrando,et al.  PHF6 mutations in adult acute myeloid leukemia , 2011, Leukemia.

[55]  Rob Pieters,et al.  PHF6 mutations in T-cell acute lymphoblastic leukemia , 2010, Nature Genetics.

[56]  Richard Durbin,et al.  Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..

[57]  Andrew P. Stubbs,et al.  The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia. , 2007, Blood.

[58]  H. Drexler,et al.  Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification , 2012, Haematologica.

[59]  Q. Wang,et al.  Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia , 2011, Haematologica.

[60]  Ahmet Zehir,et al.  Detection of mutations in myeloid malignancies through paired-sample analysis of microdroplet-PCR deep sequencing data. , 2014, The Journal of molecular diagnostics : JMD.

[61]  M. Béné.  Biphenotypic, bilineal, ambiguous or mixed lineage: strange leukemias! , 2009, Haematologica.

[62]  Alexander R. Abbas,et al.  Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data , 2005, Genes and Immunity.

[63]  Kiran C. Bobba,et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.

[64]  R. Stone,et al.  Mixed-phenotype acute leukemia: current challenges in diagnosis and therapy , 2017, Current opinion in hematology.

[65]  M. Routbort,et al.  Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing , 2018, Oncotarget.